Skincare company BeautyHealth (NASDAQ:SKIN) will be announcing earnings results tomorrow after market hours. Here’s what to expect.
BeautyHealth beat analysts’ revenue expectations by 8% last quarter, reporting revenues of $83.5 million, down 13.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ EBITDA estimates.
Is BeautyHealth a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting BeautyHealth’s revenue to decline 22.2% year on year to $63.34 million, a further deceleration from the 5.7% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.07 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. BeautyHealth has missed Wall Street’s revenue estimates three times over the last two years.
Looking at BeautyHealth’s peers in the personal care segment, some have already reported their Q1 results, giving us a hint as to what we can expect. USANA delivered year-on-year revenue growth of 9.5%, beating analysts’ expectations by 2.7%, and Estée Lauder reported a revenue decline of 9.9%, topping estimates by 1.2%. USANA traded up 5.2% following the results while Estée Lauder’s stock price was unchanged.
Read our full analysis of USANA’s results here and Estée Lauder’s results here.
There has been positive sentiment among investors in the personal care segment, with share prices up 4.9% on average over the last month. BeautyHealth’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $1.53 (compared to the current share price of $1.05).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.